It is important, however, to maintain a balanced perspective: many highly successful drugs were developed without prior human genetic validation
Animal studies, such as those summarized in a review on GLP1RA use in pregnancy, show concerning outcomes including fetal growth restriction and skeletal malformations
An example is copper-dependent enzymes lysly oxidase (cross-links collagen and elastin to rebuild connective tissues), and superoxide dismutase (major antioxidant enzyme to protect against damage/aged cells), with both contributing to collagen formation, antioxidant defenses, and extracellular matrix rebuilding
Wegovy dosing schedule: Weeks 1-4: Starting dose 0.25 mg once weekly Weeks 5-8: 0.5 mg once weekly Weeks 9-12: 1 mg once weekly Weeks 13-16: 1.7 mg once weekly Weeks 17+: 1.7 or 2.4 mg once weekly The recommended maintenance dose of Wegovy in adults is 1.7 or 2.4 mg once weekly
Sodium glucose cotransporter-2 inhibitors and heart disease: current perspectives